These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 25417631)
1. Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction. Beyazıt Y; Koçak E; Tanoğlu A Turk J Gastroenterol; 2014 Oct; 25(5):592-3. PubMed ID: 25417631 [No Abstract] [Full Text] [Related]
2. Author's reply: To PMID 25003676. Ince AT Turk J Gastroenterol; 2014 Oct; 25(5):593. PubMed ID: 25566599 [No Abstract] [Full Text] [Related]
3. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions. Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676 [TBL] [Abstract][Full Text] [Related]
4. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. Alvaro D; Macarri G; Mancino MG; Marzioni M; Bragazzi M; Onori P; Corradini SG; Invernizzi P; Franchitto A; Attili AF; Gaudio E; Benedetti A Ann Intern Med; 2007 Oct; 147(7):451-9. PubMed ID: 17909206 [TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture. Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699 [TBL] [Abstract][Full Text] [Related]
6. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses. Farina A; Dumonceau JM; Antinori P; Annessi-Ramseyer I; Frossard JL; Hochstrasser DF; Delhaye M; Lescuyer P Biochim Biophys Acta; 2014 May; 1844(5):1018-25. PubMed ID: 23806607 [TBL] [Abstract][Full Text] [Related]
7. Migration of covered biliary self-expanding metallic stents in two patients with malignant biliary obstruction. Wamsteker EJ; Elta GH Gastrointest Endosc; 2003 Nov; 58(5):792-3. PubMed ID: 14595326 [No Abstract] [Full Text] [Related]
8. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma. Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L J Gastrointest Cancer; 2024 Jun; 55(2):800-808. PubMed ID: 38280173 [TBL] [Abstract][Full Text] [Related]
9. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis. Chen CY; Shiesh SC; Tsao HC; Lin XZ Hepatogastroenterology; 2002; 49(45):616-20. PubMed ID: 12063953 [TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses. Severino V; Dumonceau JM; Delhaye M; Moll S; Annessi-Ramseyer I; Robin X; Frossard JL; Farina A Gastroenterology; 2017 Aug; 153(2):495-504.e8. PubMed ID: 28479376 [TBL] [Abstract][Full Text] [Related]
11. EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study. Weilert F; Bhat YM; Binmoeller KF; Kane S; Jaffee IM; Shaw RE; Cameron R; Hashimoto Y; Shah JN Gastrointest Endosc; 2014 Jul; 80(1):97-104. PubMed ID: 24559784 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis should be interpreted with caution. Shao F; Wang C; Qiu L; Huang Q; Hu Y Gastrointest Endosc; 2011 Nov; 74(5):1172; author reply 1172-3. PubMed ID: 22032322 [No Abstract] [Full Text] [Related]
14. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Saleem A; Leggett CL; Murad MH; Baron TH Gastrointest Endosc; 2011 Aug; 74(2):321-327.e1-3. PubMed ID: 21683354 [TBL] [Abstract][Full Text] [Related]
17. An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis. Lukic N; Visentin R; Delhaye M; Frossard JL; Lescuyer P; Dumonceau JM; Farina A Biochim Biophys Acta; 2014 May; 1844(5):1026-33. PubMed ID: 23872482 [TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical analysis for cholangiocarcinoma]. Nakagoe T; Matsuo T; Kondoh M; Yamaguchi H Nihon Rinsho; 2006 Jan; 64 Suppl 1():370-4. PubMed ID: 16457285 [No Abstract] [Full Text] [Related]
19. Mucobilia in association with a biliary cystadenocarcinoma of the caudate duct: a rare cause of malignant biliary obstruction. Chamberlain RS; Blumgart LH HPB Surg; 2000; 11(5):345-51. PubMed ID: 10674751 [TBL] [Abstract][Full Text] [Related]